Bahl & Gaynor’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,339
Closed -$1.79M 340
2023
Q4
$1.79M Sell
20,339
-7,730
-28% -$633K 0.01% 212
2023
Q3
$2.4M Sell
28,069
-9,307
-25% -$842K 0.02% 192
2023
Q2
$3.49M Buy
37,376
+203
+0.5% +$19.1K 0.02% 180
2023
Q1
$3.71M Buy
37,173
+685
+2% +$69.7K 0.02% 173
2022
Q4
$3.62M Sell
36,488
-567
-2% -$55.1K 0.02% 174
2022
Q3
$3.25M Sell
37,055
-13,189
-26% -$1.25M 0.02% 173
2022
Q2
$4.6M Buy
50,244
+1,035
+2% +$97.5K 0.03% 167
2022
Q1
$5.32M Buy
49,209
+4,073
+9% +$393K 0.04% 154
2021
Q4
$5.27M Sell
45,136
-8,775
-16% -$1.03M 0.03% 167
2021
Q3
$6.1M Buy
53,911
+310
+0.6% +$33.4K 0.04% 152
2021
Q2
$4.78M Sell
53,601
-3,409
-6% -$319K 0.03% 170
2021
Q1
$5.56M Buy
57,010
+1,439
+3% +$135K 0.04% 151
2020
Q4
$5M Buy
55,571
+22,152
+66% +$1.77M 0.03% 154
2020
Q3
$2.41M Buy
33,419
+8,845
+36% +$703K 0.02% 208
2020
Q2
$1.99M Buy
+24,574
New +$1.77M 0.02% 218

Other funds holding EXPO

Bahl & Gaynor's EXPO Position: Q1 2024 in Review

Bahl & Gaynor sold out of Exponent (EXPO) in Q1 2024, closing a stake of 20,339 shares — an estimated $1.79M sold.

Bahl & Gaynor first reported a position in EXPO in Q2 2020 and held it in 15 quarters. The position peaked at $6.1M in Q3 2021. 329 funds tracked by Wall St. Rank hold EXPO as of Q1 2024.

  • Bahl & Gaynor reported no remaining Exponent position as of Q1 2024 after selling out during the quarter.
  • Bahl & Gaynor sold 20,339 Exponent shares in Q1 2024, an estimated $1.79M.
  • Bahl & Gaynor first reported a position in Exponent in Q2 2020 and held it in 15 quarters.
  • Bahl & Gaynor's Exponent position peaked at $6.1M in Q3 2021.
  • 329 funds tracked by Wall St. Rank held Exponent as of Q1 2024.

Based on Bahl & Gaynor's 13F filing for Q1 2024, filed 10 May 2024.